GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quantum BioPharma Ltd (XCNQ:QNTM) » Definitions » Equity-to-Asset

Quantum BioPharma (XCNQ:QNTM) Equity-to-Asset : 0.86 (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Quantum BioPharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Quantum BioPharma's Total Stockholders Equity for the quarter that ended in Sep. 2024 was C$22.07 Mil. Quantum BioPharma's Total Assets for the quarter that ended in Sep. 2024 was C$25.77 Mil.

The historical rank and industry rank for Quantum BioPharma's Equity-to-Asset or its related term are showing as below:

XCNQ:QNTM' s Equity-to-Asset Range Over the Past 10 Years
Min: -25.33   Med: 0.84   Max: 1
Current: 0.86

During the past 9 years, the highest Equity to Asset Ratio of Quantum BioPharma was 1.00. The lowest was -25.33. And the median was 0.84.

XCNQ:QNTM's Equity-to-Asset is ranked better than
88.29% of 1033 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs XCNQ:QNTM: 0.86

Quantum BioPharma Equity-to-Asset Historical Data

The historical data trend for Quantum BioPharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum BioPharma Equity-to-Asset Chart

Quantum BioPharma Annual Data
Trend Aug15 Aug16 Aug17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.84 0.87 0.86 0.80 0.76

Quantum BioPharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.76 0.78 0.72 0.86

Competitive Comparison of Quantum BioPharma's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Quantum BioPharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum BioPharma's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Quantum BioPharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Quantum BioPharma's Equity-to-Asset falls into.



Quantum BioPharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Quantum BioPharma's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=17.759/23.444
=

Quantum BioPharma's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=22.066/25.774
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quantum BioPharma  (XCNQ:QNTM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Quantum BioPharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Quantum BioPharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum BioPharma Business Description

Traded in Other Exchanges
Address
199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Quantum BioPharma Headlines

From GuruFocus